145 related articles for article (PubMed ID: 26330752)
1. Amelioration of Bleomycin-induced Pulmonary Fibrosis of Rats by an Aldose Reductase Inhibitor, Epalrestat.
Li X; Shen Y; Lu Y; Yang J
Korean J Physiol Pharmacol; 2015 Sep; 19(5):401-11. PubMed ID: 26330752
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of l-mimosine on bleomycin-induced pulmonary fibrosis in rats: Role of eIF3a and p27.
Li XW; Hu CP; Li YJ; Gao YX; Wang XM; Yang JR
Int Immunopharmacol; 2015 Jul; 27(1):53-64. PubMed ID: 25957199
[TBL] [Abstract][Full Text] [Related]
3. [Interventional effect of epalrestat on renal interstitial fibrosis in unilateral ureteral obstruction rats and its mechanism].
Gao YX; Tang J; Zhang Q; Jiang LL; Li XW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Jan; 35(1):79-84. PubMed ID: 31245958
[TBL] [Abstract][Full Text] [Related]
4. Role of eukaryotic translation initiation factor 3a in bleomycin-induced pulmonary fibrosis.
Li XW; Wu YH; Li XH; Li D; Du J; Hu CP; Li YJ
Eur J Pharmacol; 2015 Feb; 749():89-97. PubMed ID: 25592322
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide down-regulates bleomycin-induced pulmonary fibrosis.
Li XW; Li XH; Du J; Li D; Li YJ; Hu CP
Can J Physiol Pharmacol; 2016 Dec; 94(12):1315-1324. PubMed ID: 27556497
[TBL] [Abstract][Full Text] [Related]
6. Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats.
Wu YH; Li XW; Li WQ; Li XH; Li YJ; Hu GY; Liu ZQ; Li D
Eur J Pharmacol; 2016 Feb; 773():42-50. PubMed ID: 26821114
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
8. [Effects of calcitonin gene-related peptide on eIF3a and p27 expression in bleomycin-induced pulmonary fibrosis of rats].
Li XW; Zuo DZ; Shen YY; Hao W
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jan; 33(1):16-21. PubMed ID: 29926601
[TBL] [Abstract][Full Text] [Related]
9. Effect of AR gene-specific knockout on the process of radiation-induced pulmonary fibrosis and its mechanism.
Zhang Z; Li Z; Chen X; Wang Y; Li X
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):156-162. PubMed ID: 37571887
[TBL] [Abstract][Full Text] [Related]
10. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
11. Role of eukaryotic translation initiation factors 3a in hypoxia-induced right ventricular remodeling of rats.
Li WQ; Li XH; Wu YH; Du J; Wang AP; Li D; Li YJ
Life Sci; 2016 Jan; 144():61-8. PubMed ID: 26612348
[TBL] [Abstract][Full Text] [Related]
12. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
13. Astragalus injection attenuates bleomycin-induced pulmonary fibrosis via down-regulating Jagged1/Notch1 in lungs.
Zhou Y; Liao S; Zhang Z; Wang B; Wan L
J Pharm Pharmacol; 2016 Mar; 68(3):389-96. PubMed ID: 26817817
[TBL] [Abstract][Full Text] [Related]
14. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
16. The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
He J; Gao HX; Yang N; Zhu XD; Sun RB; Xie Y; Zeng CH; Zhang JW; Wang JK; Ding F; Aa JY; Wang GJ
Acta Pharmacol Sin; 2019 Jan; 40(1):86-97. PubMed ID: 29930278
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition.
Wang YC; Dong J; Nie J; Zhu JX; Wang H; Chen Q; Chen JY; Xia JM; Shuai W
Apoptosis; 2017 Sep; 22(9):1147-1156. PubMed ID: 28677092
[TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways.
Zhang Y; Lu W; Zhang X; Lu J; Xu S; Chen S; Zhong Z; Zhou T; Wang Q; Chen J; Liu P
Pharmacol Res; 2019 Sep; 147():104307. PubMed ID: 31181334
[TBL] [Abstract][Full Text] [Related]
19. Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathway.
Huang X; He Y; Chen Y; Wu P; Gui D; Cai H; Chen A; Chen M; Dai C; Yao D; Wang L
BMC Pulm Med; 2016 Sep; 16(1):132. PubMed ID: 27658704
[TBL] [Abstract][Full Text] [Related]
20. Ischemic postconditioning during reperfusion attenuates oxidative stress and intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion via aldose reductase.
Wen SH; Ling YH; Li Y; Li C; Liu JX; Li YS; Yao X; Xia ZQ; Liu KX
Surgery; 2013 Apr; 153(4):555-64. PubMed ID: 23218881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
